ReSViNET Trials & Studies

RSVVW'21 - A WORLDWIDE ONLINE VIRTUAL EVENT

​On 10-12 November 2021 the ReSViNET Foundation will host its 6th conference: “RSVVW'21 - A Global Conference on Novel RSV Preventive and Therapeutic Interventions." ​The aim of the conference is to learn and to share knowledge on current research and to connect the leading worldwide stakeholders in RSV research. We endeavor to continue education on RSV and to stimulate discussions regarding the opportunities for future international collaboration and achievements in our field. 

To the RSVVW'21 website

Paper of the month

- August 2021 - 
Increasing burden of viral bronchiolitis in the pediatric intensive care unit; an observational study 

---

Learn more

- June 2021 - 
The safety and antiviral activity of a novel trivalent Nanobody against RSV (nebulised ALX-0171)

---

Learn more

- May 2021 - 
How to use potential RSV preventive interventions wisely?

---

Learn more

Go to publication archive

meet our scientific team 

The ReSViNET Foundation is the international leading non-profit organization committed to reducing the global burdens of RSV infection.

Learn more about ReSViNET

Meet our board

Out now: RESVINET T-SHIRTs

Order a ReSViNET T-Shirt and
​contribute to our research.

Order here

AWARENESS OF RSV AS A GLOBAL HEALTH PROBLEM IS LACKING

To raise and spread awareness, we have launched a ‘RSV Mortality Awareness’ campaign at the start of the RSVVW 2019 conference on November 12, 2019, by sharing a personal video entitled “Why we should all know about RSV” about Simone van Wyck, a mother, who lost her son from RSV. The RSV awareness video was produced in collaboration with the Bill & Melinda Gates Foundation.

ReSVINET and Conect4children

​News: ​ReSViNET Foundation and C4C Consortium (Conect4children) are organizing a Clinical Expert Symposium on involvement of the network in RSV clinical studies. Many thanks to the pediatricians from UK, Italy, Germany, France, Latvia, Lithuania and The Netherlands. Great meeting.

ABOUT RESVINET FOUNDATION

RSV (Respiratory Syncytial Virus) infection is the second most important cause of death during infancy, especially in developing countries. 
Since the inception of ReSViNET network in 2014, we have continuously been working to fulfill our Vision and Mission with the goal to decrease the global burden of RSV infection through the advancement of research; providing scientific input and involvement in clinical trials. ReSViNET Foundation is a financially and otherwise independent regulated entity.

ReSViNET Foundation is certified by NGOsource as equivalent to a U.S. public charity!

RSV in Older adults

We would like to express our sincere condolences to Neeltjes' family for their loss. Jan. 2020.
Neeltje from The Netherlands, 99 years old, participant of the RESCEU Older adults study. RSV is an important cause of pneumonia in older adults. Awareness of RSV in older adults is almost absent. Every year about 3-6% of all older adults are infected with RSV. Course of disease is most severe on older adults with severe underlying disease such as heart failure or COPD.
​

Read More

ReSViNET Global partners